Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: A comparative study

American Journal of Hypertension

Volumn 16, Issue 7, 2003, Pages 522-530

  Abdelhamid, Saleh ^a   Blomer, Roland ^a   Hommel, Gerhard ^b   Haack, Doris ^c   Lewicka, Sabina ^c   Fiegel, Peter ^a   Krumme, Bernd ^a  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aldosterone 18 glucuronide; Aldosterone renin ratio; Normokalemia; Primary aldosteronism; Tetrahydroaldosterone

Indexed keywords

ALDOSTERONE 18 GLUCURONIDE; ALDOSTERONE DERIVATIVE; GLUCURONIDE; TETRAHYDROALDOSTERONE; UNCLASSIFIED DRUG;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CHEMICAL PARAMETERS; COMPARATIVE STUDY; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; EVALUATION; EXERCISE; FEMALE; FOREARM; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SCREENING; SCREENING TEST; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

EID: 0037560319     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)00858-6     Document Type: Article

References (33)

1. Gordon RD, Ziesak MD, Tunny TJ, Stowasser M, Klemm SA: Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 1993;20:296-298.
2. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM: Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 1999;40:353-354.
3. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T: A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Arch Intern Med 1981;141:1589-1593.
4. Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, Yune HY, Wellman H, Donohue JP: Primary aldosteronism. Diagnosis, localization and treatment. Anal Intern Med 1979;90:386-395.
5. Bravo EL, Tarazi RC, Dustan HP, Fouad FM, Textor SC, Gifford RW, Vidt DG: The changing clinical spectrum of primary aldosteronism. Am J Med 1983;74:641-650.
6. McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S: Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 1991;73:952-957.
7. Weinberger MH, Fineberg NS: The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med 1993;153:2125-2129.
8. Vecsei P, Penke B, Joumaah A: Radioimmunoassay of free aldosterone and of its 18-oxo-glucuronide in human urine. Experientia 1972;28:730-732.
9. Gomez-Sanchez CE, Holland OB: Urinary tetrahydroaldosterone and aldosterone-18-glucoronide excretion in white and black subjects and hypertensive patients. J Clin Endocrinol Metab 1981;52:214-219.
10. Holland OB: Primary aldosteronism. Semin Nephrol 1995;15:116-125.
11. Abdelhamid S, Vecsei P, Haack D, Gless KH, Walb D, Lichtwald K, Fiegel P: Dissociation in the excretion of different aldosterone metabolites and unmetabolized (free) aldosterone in hypertension. Clin Sci 1979;57:409-414.
12. Kirkendall WM, Hammond-JJ, Thomas JC, Overturf ML, Zama A: Prazosin and clonidine for moderately severe hypertension. J Am Med Assoc 1978;240:2553-2556.
13. Brown JJ, Chinn RH, Davies DL, Fraser R, Lever AF, Rae RJ, Robertson JIS: Falsely high plasma potassium values in patients with hyperaldosteronism. Br Med J 1970;2:18-20.
14. Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME, Findling JW: Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001;86:1066-1071.
15. Vesei P, Duesterdieck G, Janhnecke J, Lommer D, Wolff HP: Secretion and turnover of aldosterone in various pathological states. Clin Sci 1969;36:241-256.
16. Glaz E, Vecsei P: Aldosterone. Akademiai Kiado, Budapest, 1971, pp 34-39.
17. Vesei P, Gless K-H: Aldosterone Radioimmuno Assay. Ferdinand Enke Verlag, Stuttgart, 1975, pp 62-68.
18. Kohl KH, Vecsel P, Abdelhamid S: Radioimmunoassay of tetrahydro-aldosterone (TH-Ald) in human urine. Acta Endrocinol (Copenh) 1978;87:596-608.
19. Haber E, Koerner T, Page LB, Kliman B, Purnode A: Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 1969;29:1349-1355.
20. Abdelhamid S, Walb D, Vecsei P: Radioimmunologische Bestimmung von Renin, Angiotensin und Aldosterone. Med Welt 1976;27:2008-2013.
21. Fardella CE, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, Pinto M, Heute A, Oestreicher E, Foradori A, Montero J: Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000;85:1863-1867.
22. Kaplan NM: Cautions over the current epidemic primary aldosteronism. Lancet 2001;357:953-954.
23. Don BR, Sebastian A, Cheitlin M, Christiansen M, Schambelan M: Pseudohyperkalemia caused by fist clenching during phlebotomy. N Engl J Med 1990;322:1290-1292.
24. Vallotton MB: Primary aldosteronism. Part I. Diagnosis of primary hyperaldosteronism. Clin Endocrinol 1996;45:47-52.
25. Oelkers W, Diederich S, Bähr V: Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage. J Clin Endocrinol Metab 2000;85:3266-3270.
26. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC: Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 2001;37:699-705.
27. Kem DC, Weinberger M, Gomez-Sanchez C, Kramer NJ, Leman R, Furuyama S, Nugent CA: Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. J Clin Investig 1973;52:2272-2277.
28. Hurter R, Nabarro JDN: Aldosterone metabolism in liver disease. Acta Endocrinol (Copenh) 1960;33:168-171.
29. Griffing GT, Wilson TE, Melby JC: Altered fractional tetrahydroaldosterone excretion during pharmacological blockade and activation of the renin-aldosterone system. J Clin Endocrinol Metab 1982;55:1217-1221.
30. Ulick S, Vetter KK: The secretion of 18-dihydroaldosterone by the human adrenal. J Clin Investig 1962;41:1406-1410.
31. Pratt JH, Holbrook M, Dale SL, Melby JC: The measurement of urinary tetrahydroaldosterone by radioimmunoassay. J Steroid Biochem 1977:8:677-681.
32. Mattox VR, Nelson AN: Determination of urinary tetrahydroaldosterone glucosidouronic acid by radioimmunoassay. J Steroid Biochem 1981;14:243-249.
33. Honour JW, Schackleton CHL: Mass spectrometric analysis for tetrahydroaldosterone. J Steroid Biochem 1977;8:299-305.